+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Rabies Vaccines Market by Vaccine Type, Vaccine Class, Route Of Administration, Formulation, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Human Rabies Vaccines Market by Vaccine Type, Vaccine Class, Route Of Administration, Formulation, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Human Rabies Vaccines Market by Vaccine Type, Vaccine Class, Route Of Administration, Formulation, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674553
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global human rabies vaccines market is characterized by dynamic growth, technological advancement, and an evolving regulatory landscape. Forward-thinking leadership is essential for navigating the complexities of this sector, from innovation and supply chain resilience to access and operational efficiency.

Market Snapshot: Human Rabies Vaccines

The Human Rabies Vaccines Market grew from USD 1.05 billion in 2024 to USD 1.10 billion in 2025. It is expected to continue growing at a CAGR of 4.64%, reaching USD 1.38 billion by 2030. Market momentum is fueled by ongoing public health initiatives, increasing awareness of preventative measures, and adoption of advanced vaccine technologies.

Scope & Segmentation

This report delivers a comprehensive analysis tailored to decision-makers, offering deep market segmentation and strategic intelligence. The following categorical breakdowns define crucial demand and adoption dynamics:

  • Vaccine Type: Post Exposure Prophylaxis, Pre Exposure Prophylaxis
  • Vaccine Class: Human Diploid Cell, Purified Chick Embryo Cell, Purified Vero Cell
  • Route Of Administration: Intradermal, Intramuscular
  • Formulation: Liquid, Lyophilized
  • End User: Clinics, Hospitals, Research Institutes
  • Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

Regional Coverage: Americas (including United States with major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, and more), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).

Company Profiles: Sanofi SA, GlaxoSmithKline plc, Bharat Biotech International Limited, Indian Immunologicals Limited, Valneva SE, China National Pharmaceutical Group Co., Ltd., PT Bio Farma (Persero) Tbk, Hualan Biological Engineering Inc., Changchun Institute of Biological Products Co., Ltd.

Key Takeaways for Decision-Makers

  • Transition from traditional nerve tissue vaccines to advanced cell culture technologies is elevating both safety and immunogenicity, expanding the range of viable prophylactic strategies for diverse populations.
  • Targeted post-exposure and pre-exposure immunization campaigns are guiding resource allocation, optimizing clinical protocols, and enhancing coverage among high-risk groups, particularly in endemic areas.
  • Emerging intradermal administration techniques are being adopted for dose-sparing and increased cost efficiency, especially in regions with limited resources and during campaign immunizations.
  • Digital solutions are sharpening real-time monitoring of cold-chain logistics and adverse events, facilitating quality assurance and compliance across extended distribution networks.
  • Collaborative strategies include cross-sector partnerships for research, modular manufacturing enhancements, and supply agreements that buffer against market volatility and regulatory change.
  • Regional distinctions affect adoption pace, with innovation hubs emerging in Asia-Pacific and multi-agency procurement partnerships playing a key role in Europe, the Middle East, and Africa.

Tariff Impact on U.S. Human Rabies Vaccine Market

Recent tariff measures introduced in 2025 have increased costs for both bulk antigens and finished vaccine imports in the United States, driving a reassessment of cost structures among local manufacturers and distribution networks. Healthcare providers and procurement entities are seeking flexible purchasing arrangements and exploring direct agreements to manage financial impacts. Federal and state policy responses are under consideration to mitigate constraints for critical public health commodities and preserve access. As manufacturers invest in process intensification and agile supply chain management, the market demonstrates both vulnerability to trade policy shifts and adaptive capability.

Methodology & Data Sources

This analysis is founded on a robust methodology, which includes a detailed review of peer-reviewed literature, regulatory filings, and clinical trial outcomes. Qualitative insights gathered from expert interviews are complemented by quantitative procurement and financial data. Cross-referenced triangulation assures consistency and reliability, with industry advisory validation throughout.

Why This Report Matters

  • Enables strategic planning aligned with evolving market segmentation and technology adoption trends in human rabies vaccines.
  • Equips procurement leaders and policymakers with actionable risk mitigation tactics for tariffs, distribution, and regulatory changes.
  • Delivers competitive benchmarking, supporting informed investment in R&D, operational efficiency, and partnership development.

Conclusion

Human rabies vaccines are at a critical point of transformation, shaped by innovation, collaboration, and policy adaptation. This report equips stakeholders to anticipate challenges and seize opportunities, supporting resilient, equitable vaccine access in a rapidly evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of WHO prequalified intradermal rabies immunization protocols to reduce per-patient dosing costs in Southeast Asia
5.2. Surge in recombinant monoclonal antibody therapy complementing rabies vaccine prophylaxis for post-exposure management in high-risk populations
5.3. Investment by biotechnology firms in human rabies vaccine thermostability improvements for cold chain-challenged regions
5.4. Regulatory harmonization initiatives accelerating approval of next-generation cell-based rabies vaccines across African and Latin American markets
5.5. Increasing integration of digital patient tracking systems to monitor multi-dose rabies vaccination compliance in rural health clinics
5.6. Emergence of single-visit rabies pre-exposure immunization platforms using sustained-release antigen delivery nanoparticles
5.7. Collaborative public-private partnerships funding mass dog vaccination campaigns as a strategic approach to reduce human rabies incidence
5.8. Development of novel adjuvant formulations enhancing immunogenicity and reducing intramuscular rabies vaccine administration burdens
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Rabies Vaccines Market, by Vaccine Type
8.1. Introduction
8.2. Post Exposure Prophylaxis
8.3. Pre Exposure Prophylaxis
9. Human Rabies Vaccines Market, by Vaccine Class
9.1. Introduction
9.2. Human Diploid Cell
9.3. Purified Chick Embryo Cell
9.4. Purified Vero Cell
10. Human Rabies Vaccines Market, by Route Of Administration
10.1. Introduction
10.2. Intradermal
10.3. Intramuscular
11. Human Rabies Vaccines Market, by Formulation
11.1. Introduction
11.2. Liquid
11.3. Lyophilized
12. Human Rabies Vaccines Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Hospitals
12.4. Research Institutes
13. Human Rabies Vaccines Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Retail Pharmacies
14. Americas Human Rabies Vaccines Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Human Rabies Vaccines Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Human Rabies Vaccines Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sanofi SA
17.3.2. GlaxoSmithKline plc
17.3.3. Bharat Biotech International Limited
17.3.4. Indian Immunologicals Limited
17.3.5. Valneva SE
17.3.6. China National Pharmaceutical Group Co., Ltd.
17.3.7. PT Bio Farma (Persero) Tbk
17.3.8. Hualan Biological Engineering Inc.
17.3.9. Changchun Institute of Biological Products Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. HUMAN RABIES VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN RABIES VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN RABIES VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. HUMAN RABIES VACCINES MARKET: RESEARCHAI
FIGURE 28. HUMAN RABIES VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 29. HUMAN RABIES VACCINES MARKET: RESEARCHCONTACTS
FIGURE 30. HUMAN RABIES VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN RABIES VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY POST EXPOSURE PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY POST EXPOSURE PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PRE EXPOSURE PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PRE EXPOSURE PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HUMAN DIPLOID CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HUMAN DIPLOID CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED CHICK EMBRYO CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED CHICK EMBRYO CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED VERO CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED VERO CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRADERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 82. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 83. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 84. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 85. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 94. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 95. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. MEXICO HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 154. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 156. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 157. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. GERMANY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 166. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 168. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 169. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 172. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 173. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. FRANCE HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 190. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 191. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 192. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 193. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ITALY HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 202. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 203. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 204. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 205. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SPAIN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 250. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 251. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 252. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 253. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 256. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 257. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. DENMARK HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 274. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 275. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 276. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 277. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. QATAR HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 286. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 287. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 288. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 289. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. FINLAND HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 322. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 323. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2024 (USD MILLION)
TABLE 324. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025-2030 (USD MILLION)
TABLE 325. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 326. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 327. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 328. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 329. EGYPT HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

  • Sanofi SA
  • GlaxoSmithKline plc
  • Bharat Biotech International Limited
  • Indian Immunologicals Limited
  • Valneva SE
  • China National Pharmaceutical Group Co., Ltd.
  • PT Bio Farma (Persero) Tbk
  • Hualan Biological Engineering Inc.
  • Changchun Institute of Biological Products Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.38 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Rabies Vaccine - Global Strategic Business Report - Product Image

Rabies Vaccine - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Inactivated Polio and Rabies Vaccines - Global Strategic Business Report - Product Image

Inactivated Polio and Rabies Vaccines - Global Strategic Business Report

  • Report
  • 470 Pages
  • Global
From
Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Inactivated Polio And Rabies Vaccines Global Market Report 2025 - Product Image

Inactivated Polio And Rabies Vaccines Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Rabies Vaccine Market

The Rabies Vaccine market is a subset of the Vaccines market, which is a global industry that produces and distributes immunizations to protect against infectious diseases. Rabies Vaccines are used to protect against the rabies virus, which is a fatal disease that is spread through the saliva of infected animals. The Rabies Vaccine market is composed of a variety of products, including pre-exposure and post-exposure vaccines, as well as combination vaccines. These products are used in both humans and animals, and are typically administered by injection. The Rabies Vaccine market is highly regulated, with stringent safety and efficacy standards in place to ensure the quality of the products. Additionally, the market is subject to a variety of government regulations, including those related to pricing and distribution. Some companies in the Rabies Vaccine market include Merck & Co., Inc., Sanofi Pasteur, GlaxoSmithKline, and Pfizer, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.